US News

U.S. FDA lifts clinical hold on Inovio’s COVID-19 vaccine trial

Published by

(Reuters) -Inovio Pharmaceuticals Inc said on Tuesday the U.S. Food and Drug Administration (FDA) had lifted a partial clinical hold on late-stage trial of its COVID-19 vaccine within the country. Inovio said it now has the authorization to proceed with the trial after 14 months, sending its shares up 4.6% before the bell. The FDA last year in September put the final-stage trial on hold as it sought more information from the company, including details on a delivery device used to inject genetic material into cells. Following the decision, the U.S. government pulled funding for the late-stage s…

Read More

Facebook Comments

Check Also

The Hidden Victims Of Biden's Border Crisis

The Hidden Victims Of Biden’s Border Crisis Authored ...